FDA Inspection 1163683 — Biomat USA, Inc
The FDA completed an inspection of Biomat USA, Inc on Feb 24, 2022 in Calexico, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 24, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Calexico, CA (United States)